Gainers and Losers in the Stock Market: Strata Skin Sciences and China SXT Pharmaceuticals Lead the Way
The stock market is always full of surprises, with some companies experiencing significant gains while others struggle and face losses. In today’s article, we will take a closer look at the biggest gainers and losers in the stock market.
Gainers:
1. Strata Skin Sciences (NASDAQ: SSKN): Strata Skin Sciences shares soared by an impressive 60.0% to reach $0.88 during Friday’s after-market session. The company currently has a market cap of $30.8 million.
2. Cue Health (NASDAQ: HLTH): Cue Health experienced a noteworthy increase of 18.15%, with shares rising to $0.19. The company’s market cap is currently valued at $29.6 million.
3. Cadrenal Therapeutics (NASDAQ: CVKD): Cadrenal Therapeutics saw a 9.67% increase in its stock, reaching $0.78. The company’s market cap stands at $10.1 million.
4. GlucoTrack (NASDAQ: GCTK): GlucoTrack stock rose by 8.98% to $0.28. The company currently has a market cap of $5.9 million.
5. Monopar Therapeutics (NASDAQ: MNPR): Monopar Therapeutics experienced an 8.82% increase in its stock, reaching $0.37. The market value of their outstanding shares stands at $5.5 million.
6. NGM Biopharmaceuticals (NASDAQ: NGM): NGM Biopharmaceuticals saw a 7.21% rise in its shares, reaching $0.92. The market value of their outstanding shares is currently at $76.1 million.
Losers:
1. China SXT Pharmaceuticals (NASDAQ: SXTC): China SXT Pharmaceuticals faced a significant decrease of 22.2% in its stock, dropping to $3.09 during Friday’s after-market session. The company’s market cap currently stands at $1.7 million.
2. Qilian Intl Hldg Gr (NASDAQ: QLI): Qilian Intl Hldg Gr experienced a 17.96% decrease in its stock, reaching $0.6. The company’s market cap is currently valued at $21.5 million.
3. Fresh2 Group (NASDAQ: FRES): Fresh2 Group shares fell by 10.12% to $0.8. The company currently has a market cap of $18.9 million.
4. MyMD Pharmaceuticals (NASDAQ: MYMD): MyMD Pharmaceuticals saw a 5.26% decrease in its shares, reaching $0.25. The company’s market cap stands at $12.4 million.
5. Pyxis Oncology (NASDAQ: PYXS): Pyxis Oncology stock decreased by 5.01% to $1.71. The company’s market cap currently stands at $75.7 million.
6. Marker Therapeutics (NASDAQ: MRKR): Marker Therapeutics stock fell by 4.91% to $5.23. The company’s market cap currently stands at $46.4 million.
It is important to note that these market fluctuations are part of the dynamic nature of the stock market. Investors should do thorough research and seek professional advice before making any investment decisions.
Disclaimer: This article was generated by Benzinga’s automated content engine and reviewed by an editor. Benzinga does not provide investment advice. All rights reserved.
